viernes, 24 de marzo de 2023

FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval | FDA

FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval | FDA

No hay comentarios: